Rupert Vessey
CIK: 0001677618
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 29, 2026TECH
BIO-TECHNE Corp
Award(A)Direct2.8K shares- - Feb 26, 2026GENB
Generate Biomedicines, Inc.
Award(A)DirectStock Option (Right to Buy)
29.6K shares- - Oct 30, 2025TECH
BIO-TECHNE Corp
Award(A)Direct1.6K shares- - Oct 24, 2024TECH
BIO-TECHNE Corp
Award(A)Direct1.5K shares- - Jul 1, 2019TECH
BIO-TECHNE Corp
Award(A)DirectStock Options (Right to Buy)
588 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 29, 2026 |  TECH BIO-TECHNE Corp | Award(A) | 2,750 | - | $0 | Direct |
| Feb 26, 2026 |  GENB Generate Biomedicines, Inc. | Award(A) Stock Option (Right to Buy) | 29,561 | - | - | Direct |
| Oct 30, 2025 | TECH BIO-TECHNE Corp | Award(A) | 1,640 | - | - | Direct |
| Oct 24, 2024 | TECH BIO-TECHNE Corp | Award(A) | 1,462 | - | $0 | Direct |
| Jul 1, 2019 | TECH BIO-TECHNE Corp | Award(A) Stock Options (Right to Buy) | 588 | - | - | Direct |
1-5 of 5 transactions
About Vessey Rupert
Vessey Rupert (SEC CIK 0001677618) files insider reports with the SEC as Director of BIO-TECHNE Corp (TECH) and Director of Generate Biomedicines, Inc. (GENB).
Signal8 holds 6 ownership filings by Vessey Rupert (1 Form 3, 5 Form 4), filed between Oct 28, 2024 and Nov 2, 2026. Those filings report 5 transactions, from Jul 1, 2019 to Oct 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vessey Rupert's filings is in MINNEAPOLIS, MN.
Recent filings by Vessey Rupert
- Oct 29, 2026: Grant or award of TECH shares (Form 4, code A).
- Feb 26, 2026: Grant or award of GENB derivative securities (Form 4, code A).
- Oct 30, 2025: Grant or award of TECH shares (Form 4, code A).
- Oct 24, 2024: Grant or award of TECH shares (Form 4, code A).
- Jul 1, 2019: Grant or award of TECH derivative securities (Form 4, code A).
Other insiders filing for BIO-TECHNE Corp (TECH)
- Hippel James, CFO
- Geist William, PRESIDENT, PROTEIN SCIENCES
- Kelderman Kim, Chief Executive Officer
- Bohnen Shane, SVP - General Counsel
- Seth Alpna, Director
- Klimovsky Judith V., Director